These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 2187912

  • 1. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
    Taylor CB, Hayward C, King R, Ehlers A, Margraf J, Maddock R, Clark D, Roth WT, Agras WS.
    J Clin Psychopharmacol; 1990 Apr; 10(2):112-8. PubMed ID: 2187912
    [Abstract] [Full Text] [Related]

  • 2. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
    Charney DS, Woods SW, Goodman WK, Rifkin B, Kinch M, Aiken B, Quadrino LM, Heninger GR.
    J Clin Psychiatry; 1986 Dec; 47(12):580-6. PubMed ID: 3536889
    [Abstract] [Full Text] [Related]

  • 3. Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment.
    Maier W, Rosenberg R, Argyle N, Buller R, Roth M, Brandon S, Benkert O.
    Eur Arch Psychiatry Clin Neurosci; 1991 Dec; 241(1):22-30. PubMed ID: 1832302
    [Abstract] [Full Text] [Related]

  • 4. Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
    Schweizer E, Rickels K, Weiss S, Zavodnick S.
    Arch Gen Psychiatry; 1993 Jan; 50(1):51-60. PubMed ID: 8422222
    [Abstract] [Full Text] [Related]

  • 5. Drug treatment of panic disorder: early response to treatment as a predictor of final outcome.
    Albus M, Lecrubier Y, Maier W, Buller R, Rosenberg R, Hippius H.
    Acta Psychiatr Scand; 1990 Nov; 82(5):359-65. PubMed ID: 2281806
    [Abstract] [Full Text] [Related]

  • 6. Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic response.
    Rosenberg R, Bech P, Mellergård M, Ottosson JO.
    Acta Psychiatr Scand Suppl; 1991 Nov; 365():46-52. PubMed ID: 1862734
    [Abstract] [Full Text] [Related]

  • 7. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.
    Ballenger JC, Burrows GD, DuPont RL, Lesser IM, Noyes R, Pecknold JC, Rifkin A, Swinson RP.
    Arch Gen Psychiatry; 1988 May; 45(5):413-22. PubMed ID: 3282478
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study.
    Andersch S, Rosenberg NK, Kullingsjö H, Ottosson JO, Bech P, Bruun-Hansen J, Hanson L, Lorentzen K, Mellergård M, Rasmussen S.
    Acta Psychiatr Scand Suppl; 1991 May; 365():18-27. PubMed ID: 1862730
    [Abstract] [Full Text] [Related]

  • 9. Response of panic disorder to fixed doses of alprazolam or imipramine.
    Uhlenhuth EH, Matuzas W, Glass RM, Easton C.
    J Affect Disord; 1989 May; 17(3):261-70. PubMed ID: 2529295
    [Abstract] [Full Text] [Related]

  • 10. Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder?
    Maier W, Roth SM, Argyle N, Buller R, Lavori P, Brandon S, Benkert O.
    Eur Arch Psychiatry Clin Neurosci; 1991 May; 241(3):151-8. PubMed ID: 1790160
    [Abstract] [Full Text] [Related]

  • 11. [Comparison of the effect of alprazolam, imipramine and placebo in the treatment of panic disorders in Cali, Colombia].
    León CA, De Arango MV, Arevalo W, Calvo A, Montoya A, León A.
    Acta Psiquiatr Psicol Am Lat; 1990 May; 36(1-2):59-72. PubMed ID: 2073024
    [Abstract] [Full Text] [Related]

  • 12. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo.
    Keller MB, Lavori PW, Goldenberg IM, Baker LA, Pollack MH, Sachs GS, Rosenbaum JF, Deltito JA, Leon A, Shear K.
    J Affect Disord; 1993 May; 28(1):27-38. PubMed ID: 8326078
    [Abstract] [Full Text] [Related]

  • 13. Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment.
    Rosenberg R, Bech P, Mellergård M, Ottosson JO.
    Acta Psychiatr Scand Suppl; 1991 May; 365():39-45. PubMed ID: 1862733
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms.
    Hoehn-Saric R, McLeod DR, Zimmerli WD.
    J Clin Psychiatry; 1988 Aug; 49(8):293-301. PubMed ID: 3045099
    [Abstract] [Full Text] [Related]

  • 15. Long-term effects of alprazolam and imipramine on cerebrospinal fluid monoamine metabolites and neuropeptides in panic disorder.
    Lepola U, Jolkkonen J, Rimón R, Riekkinen P.
    Neuropsychobiology; 1989 Aug; 21(4):182-6. PubMed ID: 2483580
    [Abstract] [Full Text] [Related]

  • 16. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.
    Pecknold JC, Swinson RP, Kuch K, Lewis CP.
    Arch Gen Psychiatry; 1988 May; 45(5):429-36. PubMed ID: 3282479
    [Abstract] [Full Text] [Related]

  • 17. Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.
    Deltito JA, Argyle N, Klerman GL.
    J Clin Psychiatry; 1991 Mar; 52(3):121-7. PubMed ID: 2005075
    [Abstract] [Full Text] [Related]

  • 18. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis.
    Boyer W.
    Int Clin Psychopharmacol; 1995 Mar; 10(1):45-9. PubMed ID: 7622804
    [Abstract] [Full Text] [Related]

  • 19. Treatment of panic disorder in older adults: a pilot study comparison of alprazolam, imipramine, and placebo.
    Sheikh JI, Swales PJ.
    Int J Psychiatry Med; 1999 Mar; 29(1):107-17. PubMed ID: 10376237
    [Abstract] [Full Text] [Related]

  • 20. Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
    Lesser IM, Rubin RT, Pecknold JC, Rifkin A, Swinson RP, Lydiard RB, Burrows GD, Noyes R, DuPont RL.
    Arch Gen Psychiatry; 1988 May; 45(5):437-43. PubMed ID: 3282480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.